The FDA said today that is looking into the causes of infections from reprocessed urological endoscopes based on “numerous” adverse event reports.
The agency said that since 2017 it has received more than 450 medical device reports — including three deaths — associated with reprocessed cystoscopes, ureteroscopes and cystourethroscopes used for viewing and accessing the urinary tract. The reports describe post-procedure infections or “other possible contamination issues” associated with cleaning and disinfecting the devices.
Get the full story on our sister site, Medical Design & Outsourcing.